What is Sarepta Therapeutics, Inc.'s pre-tax income?

Sarepta Therapeutics, Inc. (SRPT) reported pre-tax income of -$383.52M in Q1 2025.

How has Sarepta Therapeutics, Inc.'s pre-tax income changed year-over-year?

Sarepta Therapeutics, Inc.'s pre-tax income decreased by 1025.3% year-over-year, from $41.45M to -$383.52M.

What does pre-tax income mean?

Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.

Sarepta Therapeutics, Inc. SRPT Pre-Tax Income

Discontinued — last reported Q1 '25

Pre-Tax Income at other companies

PfizerPFE

$3.17B+13.8%

Regeneron PharmaceuticalsREGN

$831.2M-8.2%

BioMarin PharmaceuticalsBMRN

$141.2M-40.7%

PTC TherapeuticsPTCT

-$2.46M-100%

InsmedINSM

-$162.1M+36.6%

Capricor TherapeuticsCAPR

-$33.94M-39.2%

Other financials

Income statement

See full

Revenue$730.8M-1.9%

Operating income-$300.4M-961%

Net income$331.0M+174%

EPS (diluted)-$4.60-1,343%

Balance sheet

See full

Cash & equivalents$464.5M+92.8%

Total debt$198.5M-3.4%

Total equity$1.5B+31.7%

Total assets$3.2B-8.3%

Cash flow

See full

Operating cash flow-$202.7M+65.3%

CapEx$2.1M-95.2%

Free cash flow-$204.8M+67.3%

Valuation

See full

Market cap$1.76B-63.1%

Enterprise value$1.5B-67.2%

P/S0.8×—

Profitability

See full

Operating margin-50.8%-1.6pp

Net margin4.6%+2.4pp

FCF margin-28.7%-9.2pp

Returns & leverage

See full

Return on equity-23.6%-28.5pp

Debt / equity0.1×0.0×

Current ratio4.6×+0.6×

Where this comes from

Reported directly by Sarepta Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.

The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about Sarepta Therapeutics, Inc.'s pre-tax income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Sarepta Therapeutics, Inc.'s pre-tax income?: Sarepta Therapeutics, Inc. (SRPT) reported pre-tax income of -$383.52M in Q1 2025.
How has Sarepta Therapeutics, Inc.'s pre-tax income changed year-over-year?: Sarepta Therapeutics, Inc.'s pre-tax income decreased by 1025.3% year-over-year, from $41.45M to -$383.52M.
What does pre-tax income mean?: Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.